Found 16 matching trials
BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors
PHASE1The primary objective of this study is to assess the safety and tolerabilit...
Location
Icahn School of Medicine At Mount Sinai
Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC
PHASE2To explore the related biomarkers for safety and efficacy of the combinatio...
Location
Guangzhou Medical University Affiliated Cancer Hospital
Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma
PHASE2This study aims to investigate the efficacy and safety of low-dose radiatio...
Location
Sichuan University West China Hospital
Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base
PHASE2This prospective, single-arm, Phase II clinical trial aims to evaluate the ...
Location
Hospital of Stomatology, Sun Yat-sen University
SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
PHASE2This is a multicenter Phase II/III study evaluating the efficacy and safety...
Location
Guangdong Provincial People's Hospital
Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study
N/AEsophageal squamous cell carcinoma (ESCC) is highly prevalent in China, wit...
Location
Multiple Locations
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
PHASE1This single-center, prospective, single-arm study will evaluate whether giv...
Location
Shanghai Zhongshan Hospital
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
PHASE2This is a randomized controlled, phase II clinical study designed to explor...
Location
Shanghai First People's Hospital
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
PHASE2The purpose of this study is to assess the antitumor activity, safety, and ...
Status
Active Not Recruiting
Location
Valkyrie Clinical Trials
A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
PHASE3This study is a multicentre, randomised, parallel-controlled, open-label, 3...
Location
Renmin hosptial of Wuhan University